Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Lv

Showing results (521-530 of 522) with videos related to

Pageof 53
Sort By:
You have reached the last page of results.This site can display upto 522 results.
JAMA Oncology|March 24, 2022
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical TrialWang-Zhong Li, Xing Lv, Dan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal CancerWei-Xiong Xia, Xing Lv, Hu Liang, et al.
Pageof 53

Showing results (521-530 of 522) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 522 results.
JAMA Oncology|March 24, 2022
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical TrialWang-Zhong Li, Xing Lv, Dan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal CancerWei-Xiong Xia, Xing Lv, Hu Liang, et al.
Pageof 53